ICU Medical Inc (ICUI) is a publicly traded Healthcare sector company. As of May 21, 2026, ICUI trades at $129.31 with a market cap of $3.08B and a P/E ratio of 67.68. ICUI moved +4.60% today. Year to date, ICUI is -10.28%; over the trailing twelve months it is -4.16%. Its 52-week range spans $107.00 to $196.26. Analyst consensus is buy with an average price target of $163.50. Rallies surfaces ICUI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ICU Medical Q4 EBITDA Down 7%, Integration Delays Keep 2026 Target Below $500M: ICU Medical's Q4 Adjusted EBITDA fell 7% year-over-year, with deconsolidation of its IV Solutions unit and tariffs trimming $25 million. Completed integration of two Smiths Medical sites left 2026 EBITDA guidance below the original $500 million target, and tariffs are expected to shave about 2% of next-year revenue.
| Metric | Value |
|---|---|
| Price | $129.31 |
| Market Cap | $3.08B |
| P/E Ratio | 67.68 |
| EPS | $1.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $196.26 |
| 52-Week Low | $107.00 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.16B |
| Net Income | $46.34M |
| Gross Margin | 37.93% |
3 analysts cover ICUI: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $163.50.